Etanercept in axial spondyloarthritis
Etanercept in axial spondyloarthritis作者机构:Department of Rheumatology and ImmunologyThe First Medical CenterChinese PLA General HospitalBeijing 100853China
出 版 物:《Chinese Medical Journal》 (中华医学杂志(英文版))
年 卷 期:2022年第135卷第21期
页 面:2628-2630页
核心收录:
学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
摘 要:To the Editor:Axial spondyloarthritis(axSpA)is a chronic and progressive disease affecting the spine and sacroiliac(SI)joints,causing inflammatory back pain,stiffness,and inducing new bone formation(syndesmophytes and ultimately ankylosis in the severe forms).AxSpA consists of two subsets of patients:those with non-radiographic axSpA(nr-axSpA)and those with ankylosing spondylitis(AS),also known as radiographic axSpA.